Beximco has received the Food and Drug Administration’s blessing for Baclofen in dosage strengths of 10 and 20 mg tablets. The product is a muscle relaxant drug indicated for the treatment of muscle ...
Amneal is unveiling two generic products. The company is offering Lyvispah, a baclofen oral granules specialty product approved by the Food and Drug Administration for the treatment of spasticity ...
This was a randomized, between-subject, double-blind, placebo-controlled, human laboratory study conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD, from January 2013 ...
The approval was based upon a bioavailability study in healthy adults comparing baclofen oral tablets to Lyvispah. Amneal has announced the launch of Lyvispah ® (baclofen) oral granules for the ...
ST. PAUL, Minn.--(BUSINESS WIRE)-- Today, CNS Therapeutics announced the FDA approval of Gablofen® (baclofen injection) for use in the management of severe spasticity, giving healthcare providers a ...
A new study by Johns Hopkins Children's Center neurologists suggests that baclofen, a drug long thought to be effective in reducing the vocal and motor tics associated with Tourette syndrome, improves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback